Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2575 stock hub

HKG/2575 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2575is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2575

In the news

Latest news · HKG/2575

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-21.1

P25 -14.7P50 2P75 9.4

ROIC-12.5

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2575 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

149

Groups with data

Currency

CNY

Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	197
Enterprise value	HKD 10.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000074Q1
Last refreshed	2026-05-10
Market cap	HKD 11B
Price	HKD 21.3
Price currency	HKD
Rev Per Employee	292,448.79x
Sector	Healthcare
Sic	2836
Symbol	hkg/2575
Website	https://www.xuanzhubio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.48%
EV Earnings	-37.73x
EV/FCF	-43.99x
EV/Sales	178.91x
FCF yield	-2.12%
P/B ratio	7.24x
P/S ratio	191.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	49.67%
Gross Profit	HKD 28.6M
Gross Profit Growth	89.67%
Gross Profit Growth Q	158.78%
Net Income	HKD -273.2M
Net Income Growth Years	0%
Pretax Margin	-474.2%
Profit Per Employee	HKD -1.4M
ROA	-10.28
ROCE	-16.45
ROE	-21.1
ROIC	-12.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth	72.03x
Revenue Growth Q	140.89x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.04
Assets	HKD 1.8B
Cash	HKD 725.8M
Current Assets	HKD 958.6M
Current Liabilities	HKD 255.4M
Debt	HKD 719,988
Debt Equity	HKD 0
Debt FCF	HKD -0
Equity	HKD 1.5B
Interest Coverage	-1,882.4
Liabilities	HKD 300.6M
Long Term Assets	HKD 866.8M
Long Term Liabilities	HKD 45.2M
Net Cash	HKD 725.1M
Net Cash By Market Cap	HKD 6.57
Net Cash Growth	166.47%
Net Debt Equity	HKD -0.48
Tangible Book Value	HKD 1.1B
Tangible Book Value Per Share	HKD 2.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.75
Inventory Turnover	0.36
Net Working Capital	HKD -45.6M
Quick ratio	3.04
Working Capital	HKD 679.5M
Working Capital Turnover	HKD 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	38.72
All Time High	96.9
All Time High Change	-78.02%
All Time High Date	2025-12-12
All Time Low	19.6
All Time Low Change	8.67%
All Time Low Date	2026-05-07
ATR	3.23
Beta1y	2.75
Ch YTD	-69.79
High	21.98
High52	96.9
High52 Date	2025-12-12
High52ch	-78.02%
Low	20.2
Low52	19.6
Low52 Date	2026-05-07
Low52ch	8.67%
Ma50ch	-44.99%
RSI	29.2
RSI Monthly	0
RSI Weekly	37.27
Sharpe ratio	0.12x
Sortino ratio	0.25
Total Return	-3.15%
Tr YTD	-69.79
Tr1m	-31.42%
Tr1w	-2.65%
Tr3m	-69.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -259.7M
Operating margin	-450.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,686,950%
Net Borrowing	-1,014,527
Shares Insiders	1.82%
Shares Institutions	5.93%
Shares Out	517,947,790
Shares Qo Q	6.3%
Shares Yo Y	3.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -234.3M
Average Volume	2,392,292.55x
Bv Per Share	2.94
CAPEX	HKD -638,753
Ch1m	-31.42
Ch1w	-2.65
Ch3m	-69.26
Ch6m	-67.21
Change	5.45%
Change From Open	5.45
Close	20.2
Days Gap	0
Depreciation Amortization	31,985,815.3
Dollar Volume	39,760,710
Earnings Date	2026-03-30
EBIT	HKD -259.7M
EBITDA	HKD -228.8M
EPS	HKD -0.59
F Score	3
FCF	HKD -234.3M
FCF EV Yield	-2.27x
FCF Per Share	HKD -0.45
Financing CF	692,669,852
Fiscal Year End	December
Founded	2,008
Income Tax	HKD 6,677
Investing CF	124,359,884
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma20	26.8
Ma20ch	-20.51%
Net CF	575,305,093
Open	20.2
Position In Range	61.8
Ppne	133,268,088.8
Price Date	2026-05-08
Ptbv Ratio	9.6
Relative Volume	0.8x
Revenue	57,612,412x
Tax By Revenue	0.01x
Tr6m	-67.21%
Volume	1,866,700
Z Score	64.33

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2575 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2575?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.9%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.2%

Negative means the company is buying back shares.

Technical

HKG/2575 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.2

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2575

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2575 stock rating?

hkg/2575 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2575 analysis?

The full report lives at /stocks/hkg/2575/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2575?

The latest report frames hkg/2575 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2575 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.